Russell Kevin Klass, Vice President of Sales at Zomedica Corp. (ZOM), bought 500,000 shares at $0.12 ($60K) on 2024-11-11, disclosed to the SEC on 2024-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.12 | 210,200 | $25K | 42.0% |
| 2 | $0.12 | 289,800 | $35K | 58.0% |
| Total | $0.12 avg | 500,000 | $60K | 100% |
| Filing → |
| ZOMDF | BUY | 2025-11-14 | $15K | — | Filing → |
| ZOMDF | BUY | 2025-11-12 | $12K | — | Filing → |
| ZOMDF | BUY | 2025-11-10 | $500 | — | Filing → |